Atopie-patch-test als klinisch-experimentelles modell

Ulf Darsow; Johannes Huss-Marp; Kerstin Katzer; Stefanie Weissenbacher; Claudia Traidl-Hoffmann; Kilian Eyerich; Heidelore Hofmann; Bernadette Eberlein-König

doi:10.1007/bf03372366

Atopie-patch-test als klinisch-experimentelles modell

Ulf Darsow, Johannes Huss-Marp, Kerstin Katzer, Stefanie Weissenbacher, Claudia Traidl-Hoffmann, Kilian Eyerich, Heidelore Hofmann, Bernadette Eberlein-König

Klinik und Poliklinik für Dermatologie und Allergologie

Publikation: Beitrag in Fachzeitschrift › Übersichtsartikel › Begutachtung

Abstract

An epicutaneous patch test with allergens known to elicit IgE-mediated reactions with evaluation of eczematous skin lesions after 24-72 h (atopy patch test, APT) can be used as diagnostic tool in patients with atopic eczema. With improved standardization of methods, the APT has gained interest as controlled inflammation model for atopic eczema. This review describes the authors' recent results obtained in studies using the APT. Atopy patch test.

Titel in Übersetzung	Atopy patch test as a model for clinical-experimental studies
Originalsprache	Deutsch
Seiten (von - bis)	414-420
Seitenumfang	7
Fachzeitschrift	Allergo Journal
Jahrgang	14
Ausgabenummer	5 II
DOIs	https://doi.org/10.1007/bf03372366
Publikationsstatus	Veröffentlicht - Juli 2005

Schlagwörter

Anti-interleukin-5
Atopic eczema
Atopy patch test
Inflammation model
Itch
Pimecrolimus
Volatile organic compounds

Zugriff auf Dokument

10.1007/bf03372366

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

@article{1ec1d4a40a874906a678b0caee16b45a,

title = "Atopie-patch-test als klinisch-experimentelles modell",

abstract = "An epicutaneous patch test with allergens known to elicit IgE-mediated reactions with evaluation of eczematous skin lesions after 24-72 h (atopy patch test, APT) can be used as diagnostic tool in patients with atopic eczema. With improved standardization of methods, the APT has gained interest as controlled inflammation model for atopic eczema. This review describes the authors' recent results obtained in studies using the APT. Atopy patch test.",

keywords = "Anti-interleukin-5, Atopic eczema, Atopy patch test, Inflammation model, Itch, Pimecrolimus, Volatile organic compounds",

author = "Ulf Darsow and Johannes Huss-Marp and Kerstin Katzer and Stefanie Weissenbacher and Claudia Traidl-Hoffmann and Kilian Eyerich and Heidelore Hofmann and Bernadette Eberlein-K{\"o}nig",

year = "2005",

month = jul,

doi = "10.1007/bf03372366",

language = "Deutsch",

volume = "14",

pages = "414--420",

journal = "Allergo Journal",

issn = "0941-8849",

publisher = "Springer International Publishing AG",

number = "5 II",

}

TY - JOUR

T1 - Atopie-patch-test als klinisch-experimentelles modell

AU - Darsow, Ulf

AU - Huss-Marp, Johannes

AU - Katzer, Kerstin

AU - Weissenbacher, Stefanie

AU - Traidl-Hoffmann, Claudia

AU - Eyerich, Kilian

AU - Hofmann, Heidelore

AU - Eberlein-König, Bernadette

PY - 2005/7

Y1 - 2005/7

N2 - An epicutaneous patch test with allergens known to elicit IgE-mediated reactions with evaluation of eczematous skin lesions after 24-72 h (atopy patch test, APT) can be used as diagnostic tool in patients with atopic eczema. With improved standardization of methods, the APT has gained interest as controlled inflammation model for atopic eczema. This review describes the authors' recent results obtained in studies using the APT. Atopy patch test.

AB - An epicutaneous patch test with allergens known to elicit IgE-mediated reactions with evaluation of eczematous skin lesions after 24-72 h (atopy patch test, APT) can be used as diagnostic tool in patients with atopic eczema. With improved standardization of methods, the APT has gained interest as controlled inflammation model for atopic eczema. This review describes the authors' recent results obtained in studies using the APT. Atopy patch test.

KW - Anti-interleukin-5

KW - Atopic eczema

KW - Atopy patch test

KW - Inflammation model

KW - Itch

KW - Pimecrolimus

KW - Volatile organic compounds

UR - http://www.scopus.com/inward/record.url?scp=23944457350&partnerID=8YFLogxK

U2 - 10.1007/bf03372366

DO - 10.1007/bf03372366

M3 - Übersichtsartikel

AN - SCOPUS:23944457350

SN - 0941-8849

VL - 14

SP - 414

EP - 420

JO - Allergo Journal

JF - Allergo Journal

IS - 5 II

ER -

Atopie-patch-test als klinisch-experimentelles modell

Abstract

Schlagwörter

Zugriff auf Dokument

Andere Dateien und Links

Fingerprint

Dieses zitieren